Search company, investor...

Total Raised

$6.92M

Investors Count

1

Deal Terms

1

Funding, Valuation & Revenue

6 Fundings

Dipexium Pharmaceuticals has raised $6.92M over 6 rounds.

Dipexium Pharmaceuticals's latest funding round was a Merger for on April 19, 2017.

Dipexium Pharmaceuticals's valuation in March 2014 was $92.19M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/19/2017

Merger

$99M

0

FY undefined

1

3/13/2014

IPO

$99M

$92.19M

0

FY undefined

10

7/22/2013

Angel - III

$99M

$99M

0

FY undefined

10

2/25/2013

Unattributed

$99M

$99M

0

FY undefined

10

4/23/2012

Angel - II

$99M

$99M

0

FY undefined

10

Date

4/19/2017

3/13/2014

7/22/2013

2/25/2013

4/23/2012

Round

Merger

IPO

Angel - III

Unattributed

Angel - II

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$92.19M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Dipexium Pharmaceuticals Deal Terms

1 Deal Term

Dipexium Pharmaceuticals's deal structure is available for 1 funding round, including their IPO from March 13, 2014.

Round

IPO

Funding Date

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

$99M

$99M

$99M

$99M

$99M

$99M

Dipexium Pharmaceuticals Investors

1 Investors

Dipexium Pharmaceuticals has 1 investors. PLx Pharma invested in Dipexium Pharmaceuticals's Merger funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/19/2017

4/19/2017

1
Merger

Corporation

New Jersey

First funding

4/19/2017

Last Funding

4/19/2017

Investor

Rounds

1
Merger

Board Seats

Type

Corporation

Location

New Jersey

Dipexium Pharmaceuticals Acquisitions

1 Acquisition

Dipexium Pharmaceuticals acquired 1 company. Their latest acquisition was PLx Pharma on December 22, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/22/2016

Debt

$99M

$40.32M

Reverse Merger

3

Date

12/22/2016

Investment Stage

Debt

Companies

Valuation

$99M

Total Funding

$40.32M

Note

Reverse Merger

Sources

3

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.